Craig Bijou
Stock Analyst at B of A Securities
(3.78)
# 726
Out of 5,008 analysts
63
Total ratings
60%
Success rate
55.14%
Average return
Main Sectors:
Stocks Rated by Craig Bijou
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| RXST RxSight | Maintains: Underperform | $18 → $9 | $8.49 | +6.01% | 2 | Jul 9, 2025 | |
| PRCT PROCEPT BioRobotics | Maintains: Buy | $104 → $84 | $35.24 | +138.37% | 4 | Apr 25, 2025 | |
| TFX Teleflex | Downgrades: Underperform | $235 → $140 | $127.71 | +9.62% | 5 | Mar 4, 2025 | |
| BLCO Bausch + Lomb | Maintains: Underperform | $18 → $17 | $14.89 | +14.17% | 3 | Feb 20, 2025 | |
| GMED Globus Medical | Upgrades: Neutral | $80 → $97 | $60.17 | +61.21% | 4 | Jan 9, 2025 | |
| IART Integra LifeSciences Holdings | Maintains: Underperform | $26 → $18 | $14.50 | +24.14% | 13 | Oct 7, 2024 | |
| ITGR Integer Holdings | Maintains: Buy | $135 → $145 | $105.38 | +37.60% | 3 | Oct 1, 2024 | |
| MMSI Merit Medical Systems | Maintains: Neutral | $92 → $103 | $83.31 | +23.63% | 3 | Sep 16, 2024 | |
| HAE Haemonetics | Initiates: Neutral | $85 | $49.55 | +71.54% | 1 | Sep 11, 2024 | |
| GEHC GE HealthCare Technologies | Maintains: Neutral | $94 → $86 | $76.41 | +12.55% | 2 | May 1, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Buy | $95 | $70.11 | +35.50% | 1 | Oct 30, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $43 → $36 | $14.49 | +148.45% | 2 | Jan 18, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $23 → $45 | $9.08 | +395.59% | 3 | May 13, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Overweight | $15 → $120 | $5.49 | +2,085.79% | 2 | Mar 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $60 → $30 | $5.01 | +498.80% | 5 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $17 → $13 | $15.23 | -14.64% | 2 | Mar 24, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $48 → $42 | $14.17 | +196.40% | 3 | Feb 25, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterates: Overweight | $207 → $230 | $449.69 | -48.85% | 1 | Jan 10, 2020 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Neutral | $190 → $230 | $366.28 | -37.21% | 4 | Jul 26, 2019 |
RxSight
Jul 9, 2025
Maintains: Underperform
Price Target: $18 → $9
Current: $8.49
Upside: +6.01%
PROCEPT BioRobotics
Apr 25, 2025
Maintains: Buy
Price Target: $104 → $84
Current: $35.24
Upside: +138.37%
Teleflex
Mar 4, 2025
Downgrades: Underperform
Price Target: $235 → $140
Current: $127.71
Upside: +9.62%
Bausch + Lomb
Feb 20, 2025
Maintains: Underperform
Price Target: $18 → $17
Current: $14.89
Upside: +14.17%
Globus Medical
Jan 9, 2025
Upgrades: Neutral
Price Target: $80 → $97
Current: $60.17
Upside: +61.21%
Integra LifeSciences Holdings
Oct 7, 2024
Maintains: Underperform
Price Target: $26 → $18
Current: $14.50
Upside: +24.14%
Integer Holdings
Oct 1, 2024
Maintains: Buy
Price Target: $135 → $145
Current: $105.38
Upside: +37.60%
Merit Medical Systems
Sep 16, 2024
Maintains: Neutral
Price Target: $92 → $103
Current: $83.31
Upside: +23.63%
Haemonetics
Sep 11, 2024
Initiates: Neutral
Price Target: $85
Current: $49.55
Upside: +71.54%
GE HealthCare Technologies
May 1, 2024
Maintains: Neutral
Price Target: $94 → $86
Current: $76.41
Upside: +12.55%
Oct 30, 2023
Initiates: Buy
Price Target: $95
Current: $70.11
Upside: +35.50%
Jan 18, 2022
Maintains: Buy
Price Target: $43 → $36
Current: $14.49
Upside: +148.45%
May 13, 2020
Reiterates: Overweight
Price Target: $23 → $45
Current: $9.08
Upside: +395.59%
Mar 25, 2020
Maintains: Overweight
Price Target: $15 → $120
Current: $5.49
Upside: +2,085.79%
Mar 24, 2020
Maintains: Neutral
Price Target: $60 → $30
Current: $5.01
Upside: +498.80%
Mar 24, 2020
Reiterates: Overweight
Price Target: $17 → $13
Current: $15.23
Upside: -14.64%
Feb 25, 2020
Maintains: Neutral
Price Target: $48 → $42
Current: $14.17
Upside: +196.40%
Jan 10, 2020
Reiterates: Overweight
Price Target: $207 → $230
Current: $449.69
Upside: -48.85%
Jul 26, 2019
Maintains: Neutral
Price Target: $190 → $230
Current: $366.28
Upside: -37.21%